Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?

Renewing interest in immune aspects of schizophrenia and new findings about the brain-fat axis encourage us to discuss the possible role of interleukin-6 (IL-6) in schizophrenia. Previously, it was suggested that a primary alteration of the innate immune system may be relevant in schizophrenia. Func...

Descripción completa

Detalles Bibliográficos
Autores principales: Borovcanin, Milica Milovan, Jovanovic, Ivan, Radosavljevic, Gordana, Pantic, Jelena, Minic Janicijevic, Slavica, Arsenijevic, Nebojsa, Lukic, Miodrag L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681495/
https://www.ncbi.nlm.nih.gov/pubmed/29163240
http://dx.doi.org/10.3389/fpsyt.2017.00221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681495/
https://www.ncbi.nlm.nih.gov/pubmed/29163240
http://dx.doi.org/10.3389/fpsyt.2017.00221

Ejemplares similares